• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Life Science Reagents Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 Product Image

Life Science Reagents Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

  • ID: 2833252
  • April 2014
  • Region: Global
  • 128 Pages
  • Transparency Market Research

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • bioMerieux, Inc.
  • GE Healthcare Ltd.
  • Merck Millipore
  • Promega Corporation
  • Sigma-Aldrich Corporation
  • MORE

'Life Science Reagents Market (Products - PCR Reagent Kits, Cell and Tissue Culture, Flow Cytometry, Electrophoresis, Chromatography, In-Vitro Diagnostic Reagents and Others; End Users - Commercial and Contract Manufacturers, Research and Academic Institutions, Clinical Laboratories, and Forensic Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019'

This report covers the market analysis for various reagents used in the life science industry. Continuous innovation in biotechnology is driving the life science reagents market towards remarkable growth. The stakeholders for this study include manufacturers and providers of life science reagents.

The global life science reagents market is categorized on the basis of various products that are commercially available and end users of life science reagents. The different product categories covered in this report include polymerase chain reaction (PCR) reagent kits, cell and tissue culture reagents, flow cytometry reagents, chromatography reagents, in-vitro diagnostic (IVD) reagents and others (gene expression reagents, mass spectroscopy reagents and transfection reagents).

The READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • bioMerieux, Inc.
  • GE Healthcare Ltd.
  • Merck Millipore
  • Promega Corporation
  • Sigma-Aldrich Corporation
  • MORE

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 List of Abbreviations

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Life Science Reagents Market
2.2 Comparative Analysis: Global Life Science Reagents Market, By Geography, 2012 & 2019 (Value %)

Chapter 3 Life Science Reagents Market Overview
3.1 Overview – Current Market Scenario and Future Market Trends
3.2 Market Drivers
3.2.1 Technological Advancements
3.2.2 Rise in Government Initiatives in the Field of Biotechnology Industry
3.3 Market Restraints
3.3.1 Lack of Skilled Labour
3.3.2 Large Patent Repositories with Few Market Players
3.3.3 High Capital Investment
3.4 Market Opportunities
3.4.1 Developing Biotechnology Industry in Emerging Economies
3.4.2 Growing Scope of In-vitro Diagnostics Market
3.5 Porter’s Five Forces Analysis: Global Life Science Reagents Market
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Threat of New Entrants
3.5.4 Threat of Substitutes
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis: Global Life Science Reagents Market, by Geography
3.7 Competitive Landscape
3.7.1 Heat Map Analysis: Global Life Science Reagents Market, by Key Players

Chapter 4 Global Life Science Reagents Market, by Products
4.1 Overview – Current Market Scenario and Future Market Trends
4.1.1 Global Life Science Reagents Market Revenue, by Technology, 2011 – 2019 (USD Million)
4.1.2 Comparative Analysis: Global Life Science Reagents Market, by Products, 2012 & 2019 (Value %)
4.1.3 Polymerase Chain Reaction (PCR) Reagent Kits
4.1.3.1 Global Polymerase Chain Reaction (PCR) Reagent Kits Market Revenue, 2011 – 2019 (USD Million)
4.1.4 Cell and Tissue Culture Reagents
4.1.4.1 Global Cell and Tissue Culture Reagents Market Revenue, 2011 – 2019 (USD Million)
4.1.5 Flow Cytometry Reagents
4.1.5.1 Global Flow Cytometry Reagents Market Revenue, 2011 – 2019 (USD Million)
4.1.6 Electrophoresis Reagents
4.1.6.1 Global Electrophoresis Reagents Market Revenue, 2011 – 2019 (USD Million)
4.1.7 Chromatography Reagents
4.1.7.1 Global Chromatography Reagents Market Revenue, 2011 – 2019 (USD Million)
4.1.8 In-vitro Diagnostics Reagents
4.1.8.1 Immunoassay Reagents
4.1.8.2 Coagulation Reagents
4.1.8.3 Microbiology Reagents
4.1.8.4 Others
4.1.8.5 Global In-vitro Diagnostics Reagents Market Revenue, 2011 – 2019 (USD Million)
4.1.9 Other Reagents
4.1.9.1 Global Other Life Science Reagents Market Revenue, 2011 – 2019 (USD Million)

Chapter 5 Global Life Science Reagents Market, by End Users
5.1 Overview – Current Market Scenario and Future Market Trends
5.1.1 Global Life Science Reagents Market Revenue, by End Users, 2011 – 2019 (USD Million)
5.1.2 Comparative Analysis: Global Life Science Reagents Market, by End Users, 2012 & 2019 (Value %)
5.1.3 Commercial and Contract Manufacturers
5.1.3.1 Global Commercial and Contract Manufacturers Market Revenue, 2011 – 2019 (USD Million)
5.1.4 Research and Academic Institutions
5.1.4.1 Global Research and Academic Institutions Market Revenue, 2011 – 2019 (USD Million)
5.1.5 Clinical Laboratories
5.1.5.1 Global Clinical Laboratories Market Revenue, 2011 – 2019 (USD Million)
5.1.6 Forensic Laboratories
5.1.6.1 Global Forensic Laboratories Market Revenue, 2011 – 2019 (USD Million)

Chapter 6 Global Life Science Reagents Market, by Geography
6.1 Overview – Current Market Scenario and Future Market Trends
6.1.1 Global Life Science Reagents Market Revenue, by Geography, 2011 - 2019 (USD Million)
6.2 North America
6.2.1 North America Life Science Reagents Market Revenue, 2011 - 2019 (USD Million)
6.3 Europe
6.3.1 Europe Life Science Reagents Market Revenue, 2011 – 2019 (USD Million)
6.4 Asia-Pacific
6.4.1 Asia-Pacific Life Science Reagents Market Revenue, 2011 – 2019 (USD Million)
6.5 Rest of the World (RoW)
6.5.1 RoW Life Science Reagents Market Revenue, 2011 – 2019 (USD Million)

Chapter 7 Recommendations
7.1 Investment in Innovative Technologies
7.2 Investing in Emerging Economies

Chapter 8 Company Profiles
8.1 Abbott Laboratories, Inc.
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Developments
8.2 Agilent Technologies, Inc.
8.2.1 Company Overview
8.2.2 Financial Overview
8.2.3 Product Portfolio
8.2.4 Business Strategies
8.2.5 Recent Developments
8.3 Becton, Dickinson and Company
8.3.1 Company Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.5 Recent Developments
8.4 Beckman Coulter, Inc.
8.4.1 Company Overview
8.4.2 Financial Overview
8.4.3 Product Portfolio
8.4.4 Business Strategies
8.4.5 Recent Developments
8.5 bioMerieux, Inc.
8.5.1 Company Overview
8.5.2 Financial Overview
8.5.3 Product Portfolio
8.5.4 Business Strategies
8.5.5 Recent Developments
8.6 Bio-Rad Laboratories, Inc.
8.6.1 Company Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Business Strategies
8.6.5 Recent Developments
8.7 F. Hoffman-La Roche, Ltd.
8.7.1 Company Overview
8.7.2 Financial Overview
8.7.3 Product Portfolio
8.7.4 Business Strategies
8.7.5 Recent Developments
8.8 GE Healthcare Ltd.
8.8.1 Company Overview
8.8.2 Financial Overview
8.8.3 Product Portfolio
8.8.4 Business Strategies
8.8.5 Recent Developments
8.9 Life Technologies Corporation
8.9.1 Company Overview
8.9.2 Financial Overview
8.9.3 Product Portfolio
8.9.4 Business Strategies
8.9.5 Recent Developments
8.10 Lonza Group Ltd.
8.10.1 Company Overview
8.10.2 Financial Overview
8.10.3 Product Portfolio
8.10.4 Business Strategies
8.10.5 Recent Developments
8.11 Merck Millipore
8.11.1 Company Overview
8.11.2 Financial Overview
8.11.3 Product Portfolio
8.11.4 Business Strategies
8.11.5 Recent Developments
8.12 Meridian Life Science, Inc.
8.12.1 Company Overview
8.12.2 Financial Overview
8.12.3 Product Portfolio
8.12.4 Business Strategies
8.12.5 Recent Developments
8.13 PerkinElmer, Inc.
8.13.1 Company Overview
8.13.2 Financial Overview
8.13.3 Product Portfolio
8.13.4 Business Strategies
8.13.5 Recent Developments
8.14 Promega Corporation
8.14.1 Company Overview
8.14.2 Financial Overview
8.14.3 Product Portfolio
8.14.4 Business Strategies
8.14.5 Recent Developments
8.15 Siemens Healthcare
8.15.1 Company Overview
8.15.2 Financial Overview
8.15.3 Product Portfolio
8.15.4 Business Strategies
8.15.5 Recent Developments
8.16 Sigma-Aldrich Corporation
8.16.1 Company Overview
8.16.2 Financial Overview
8.16.3 Product Portfolio
8.16.4 Business Strategies
8.16.5 Recent Developments
8.17 Sysmex Corporation
8.17.1 Company Overview
8.17.2 Financial Overview
8.17.3 Product Portfolio
8.17.4 Business Strategies
8.17.5 Recent Developments
8.18 Waters Corporation
8.18.1 Company Overview
8.18.2 Financial Overview
8.18.3 Product Portfolio
8.18.4 Business Strategies
8.18.5 Recent Developments

List of Figures

FIG. 1 Life Science Reagents Market Segmentation
FIG. 2 Global Life Science Reagents Market Revenue, by Products, 2012 (USD Million)
FIG. 3 Global Life Science Reagents Market Revenue, by End Users, 2012 (USD Million)
FIG. 4 Comparative Analysis: Global Life Science Reagents Market, by Geography, 2012 & 2019 (Value %)
FIG. 5 Porter’s Five Forces Analysis: Global Life Science Reagents Market
FIG. 6 Market Attractiveness Analysis: Global Life Science Reagents Market, by Geography
FIG. 7 Heat Map Analysis: Global Life Science Reagents Market, by Key Players
FIG. 8 Comparative Analysis: Global Life Science Reagents Market, by Products, 2012 & 2019 (Value %)
FIG. 9 Global Polymerase Chain Reaction (PCR) Reagent Kits Market Revenue, 2011 – 2019 (USD Million)
FIG. 10 Global Cell and Tissue Culture Reagents Market Revenue, 2011 - 2019 (USD Million)
FIG. 11 Global Flow Cytometry Reagents Market Revenue, 2011 – 2019 (USD Million)
FIG. 12 Global Electrophoresis Reagents Market Revenue, 2011 – 2019 (USD Million)
FIG. 13 Global Chromatography Reagents Market Revenue, 2011 – 2019 (USD Million)
FIG. 14 Global In-vitro Diagnostics Reagents Market Revenue, 2011 – 2019 (USD Million)
FIG. 15 Global Other Life Science Reagents Market Revenue, 2011 – 2019 (USD Million)
FIG. 16 Comparative Analysis: Global Life Science Reagents Market, by End Users, 2012 & 2019 (Value %)
FIG. 17 Global Commercial and Contract Manufacturers Market Revenue, 2011 – 2019 (USD Million)
FIG. 18 Global Research and Academic Institutions Market Revenue, 2011 - 2019 (USD Million)
FIG. 19 Global Clinical Laboratories Market Revenue, 2011 – 2019 (USD Million)
FIG. 20 Global Forensic Laboratories Market Revenue, 2011 – 2019 (USD Million)
FIG. 21 North America Life Science Reagents Market Revenue, 2011 - 2019 (USD Million)
FIG. 22 Europe Life Science Reagents Market Revenue, 2011 - 2019 (USD Million)
FIG. 23 Asia-Pacific Life Science Reagents Market Revenue, 2011 – 2019 (USD Million)
FIG. 24 RoW Life Science Reagents Market Revenue, 2011 - 2019 (USD Million)
FIG. 25 Abbott Laboratories, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 26 Agilent Technologies, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 27 Becton, Dickinson and Company: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 28 bioMerieux, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 29 Bio-Rad Laboratories, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 30 F. Hoffman-La Roche, Ltd.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 31 GE Healthcare: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 32 Life Technologies Corporation: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 33 Lonza Group, Ltd.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 34 Merck Millipore: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 35 Meridian Life Science, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 36 PerkinElmer, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 37 Siemens Healthcare: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 38 Sigma-Aldrich Corporation: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 39 Sysmex Corporation: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 40 Waters Corporation: Annual Revenue, 2010 – 2012 (USD Million)

List of Tables

TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Life Science Reagents Market
TABLE 3 Global Life Science Reagents Market Revenue, by Products, 2011 – 2019 (USD Million)
TABLE 4 Global Life Science Reagents Market Revenue, by End Users, 2011 – 2019 (USD Million)
TABLE 5 Global Life Science Reagents Market Revenue, by Geography 2011 – 2019 (USD Million)

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • bioMerieux, Inc.
  • GE Healthcare Ltd.
  • Merck Millipore
  • Promega Corporation
  • Sigma-Aldrich Corporation
  • MORE

Life science reagents include reagents that are used in biotechnology, bioscience and pharmaceutical industries. Since the last decade, the global life science reagents market has experienced impressive growth due to factors such as technology advancement and expansion in applications of biotechnology and biosciences in the field of healthcare and pharmaceuticals. Some other factors contributing to the growth of the life science reagents market include increasing disease prevalence and rise in their mortality rates, aging of population and increased research and development activities in the field of biosciences, biotechnology and pharmaceuticals. Based on the commercially available life science reagent products, the global life science reagents market is categorized as PCR reagent kits, cell and tissue culture reagents, flow cytometry reagents, electrophoresis reagents, chromatography reagents, in-vitro diagnostic reagents and others. In addition, the global life science reagents market is segmented on the basis of end users, namely, commercial and contract manufacturers, research and academics, clinical laboratories, and forensic laboratories.

Chromatography reagents are the most widely used reagent products thus, capturing the highest market share in the overall life science reagents market. Wide use of chromatography in almost every aspect of biotechnology-related research and product development is the prime contributing factor for the dominance of this segment. On the other hand, the market share of electrophoresis reagents is the lowest as compared to other products available in the overall life science reagents market. Technological advancement and increasing initiatives towards the expansion of scope of biotechnology and life science has led to perpetual rise in demand for life science reagents worldwide.

In terms of end users, research and academic institutions are the largest consumers of life science reagents. Technological development and corresponding rise in the number of available skilled labor in emerging economies have widened the scope for research outsourcing in the developing markets of India and Brazil. Processes such as pharmaceutical contract manufacturing and cosmetic product manufacturing constitute the largest commercial consumers of life science reagents. Due to the requirement of high capital investment to perform stability studies, formulation development and phase-I trials, several pharmaceutical companies outsource drug development operations to contract manufacturing companies to focus on their core activities of manufacturing drugs and marketing, thereby controlling the in-house budget.

The global life science reagents market is fragmented in terms of presence of a large number of multinational and local players. The mature market players such as Sigma Aldrich, Abbott Laboratories, Life Technologies, Bio-Rad and others currently dominate this market with their patent protected products and intensive growth strategies of acquiring new market entrants providing breakthrough technologies. In addition, large patent repositories of the established market players restrains the entry and growth of new players in the life science reagents market.

Geographically, North America dominates the global life science reagents market and is followed by Europe. Asia-Pacific is expected to show the highest growth rate owing to factors such as increasing research and development activities, rise in the number of government aids, business clusters and trade conglomerates to strengthen biotechnology industry in the respective national markets and rise in the availability of skilled manpower at cheaper cost, thereby increasing the scope for outsourcing of biotech projects. New trend of outsourcing research activities in Asia-Pacific is one of the major driving forces for the growth of the life science reagents market in this region. Countries such as Brazil, Mexico and Argentina in the Rest of the World (RoW) region are adopting strategies such as formation of biotechnology clusters and attracting foreign investments to boost the domestic biotechnology industry. However, stringent regulatory rules restrain the entry of new products in the market and thus, restrict the growth of life science reagents market in these countries.

Note: Product cover images may vary from those shown

- Abbott Laboratories, Inc.
- Agilent Technologies, Inc.
- Becton, Dickinson and Companys
- Beckman Coulter, Inc.
- bioMerieux, Inc.
- Bio-Rad Laboratories, Inc.
- F. Hoffman-La Roche, Ltd.
- GE Healthcare Ltd.
- Life Technologies Corporation
- Lonza Group Ltd.
- Merck Millipore
- Meridian Life Science, Inc.
- PerkinElmer, Inc.
- Promega Corporation
- Siemens Healthcare
- Sigma-Aldrich Corporation
- Sysmex Corporation
- Waters Corporation

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos